- Joined
- Jan 8, 2010
- Messages
- 72,131
- Reaction score
- 58,867
- Location
- NE Ohio
- Gender
- Male
- Political Leaning
- Liberal
Pfizer and its German partner, BioNTech, said Monday that an early analysis showed their three-dose coronavirus vaccine regimen triggered a strong immune response in younger children, proving 80 percent effective at preventing symptomatic infections in children 6 months to 4 years old.
The results, along with other recent developments, signal that the long and frustrating wait for a vaccine for the youngest children, the last group to lack access, could be over within weeks.
Good news! This is one step closer to making sure everyone has the vaccine available to them.